Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...
"Everything injected into the bloodstream is eventually ends up in the liver — that's just how our anatomy works," Professor ...
PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...
Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...
A common antihistamine may offer hope for patients with a rare genetic disease that can lead to severe liver damage and ...
Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce ...
Researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants.
SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.
Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results